This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Aug 18;304(7):793-4.

doi: 10.1001/jama.2010.1161.

Minimizing bias in randomized trials: the importance of blinding

Bruce M Psaty¹, Ross L Prentice

Affiliations

Affiliation

¹ Cardiovascular Health Research Unit, Department of Medicine, University of Washington and Center for Health Studies, Group Health, Seattle, WA 98101, USA. psaty@u.washington.edu

PMID: 20716744
DOI: 10.1001/jama.2010.1161

Minimizing bias in randomized trials: the importance of blinding

Bruce M Psaty et al. JAMA. 2010.

. 2010 Aug 18;304(7):793-4.

doi: 10.1001/jama.2010.1161.

Authors

Bruce M Psaty¹, Ross L Prentice

Affiliation

¹ Cardiovascular Health Research Unit, Department of Medicine, University of Washington and Center for Health Studies, Group Health, Seattle, WA 98101, USA. psaty@u.washington.edu

PMID: 20716744
DOI: 10.1001/jama.2010.1161

No abstract available

PubMed Disclaimer

Comment in

Importance of blinding in randomized trials.
Strite SA, Stuart ME. Strite SA, et al. JAMA. 2010 Nov 17;304(19):2127-8; author reply 2128. doi: 10.1001/jama.2010.1621. JAMA. 2010. PMID: 21081725 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems